Las Condes

53 / 160

53
REFERENCIAS BIBLIOGRÁFICAS
1. Lodrup Carlsen KC, Hedlin G, Bush A, et al. Assessment of
problematic severe asthma in children. Eur Respir J. Feb
2011;37(2):432-440.
2. Konradsen JR, et al. Problematic severe asthma: a proposed
approach to identifying children who are severely resistant to
therapy. Pediatr Allergy Immunol. 2011;22(1 Pt 1):9–18.
3. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS
guidelines on definition, evaluation and treatment of severe
asthma. Eur.Respir.J. 2014;43(2):343-373.
4.
04001011f014e64.pdf.
5. Fitzpatrick AM. Severe Asthma in Children: Lessons Learned
and Future Directions. The journal of allergy and clinical
immunology. In practice. Jan-Feb 2016;4(1):11-19.
6. Reddel HK, Bateman ED, Becker A, et al. A summary of the
new GINA strategy: a roadmap to asthma control. Eur Respir
J. Sep 2015;46(3):622-639.
7. Bossley CJ, Fleming L, Gupta A, et al. Pediatric severe asthma
is characterized by eosinophilia and remodeling without
T(H)2 cytokines. J.Allergy Clin.Immunol. 2012;129(4):974-
982.
8. Griffiths C, Levy ML. Preventing avoidable asthma deaths. The
Practitioner. Sep 2014;258(1774):27-31, 23.
9. Levy ML. The national review of asthma deaths: what did
we learn and what needs to change? Breathe (Sheffield,
England). Mar 2015;11(1):14-24.
10. Lindsay JT, Heaney LG. Non-adherence in difficult asthma and
advances in detection. Expert review of respiratory medicine.
Dec 2013;7(6):607-614.
11. Eakin MN, Rand CS. Improving patient adherence with
asthma self-management practices: what works? Annals of
allergy, asthma & immunology : official publication of the
American College of Allergy, Asthma, & Immunology. Aug
2012;109(2):90-92.
12. Krishnan JA, Bender BG, Wamboldt FS, Szefler SJ, Adkinson
NF Jr, Zeiger RS, et al. Adherence to inhaled corticosteroids:
an ancillary study of the Childhood Asthma Management
Program clinical trial. J Allergy Clin Immunol 2012;129:
112-8).
13. Engelkes M, Janssens HM, de Jongste JC, Sturkenboom MC,
Verhamme KM. Medication adherence and the risk of severe
asthma exacerbations: a systematic review. Eur Respir J
2015;45:396-407).
14. Weinstein AG. Asthma adherence management for the
clinician. J Allergy Clin Immunol Pract 2013;1:123-8.
15. Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM.
Adherence monitoring and e-health: how clinicians and
El autor declara no tener conflictos de interés, en relación a este artículo.
researchers can use technology to promote inhaler adherence
for asthma. J Allergy Clin Immunol Pract 2013;1: 446-54.
16. Guilbert TW, Bacharier LB, Fitzpatrick AM. Severe asthma in
children. J Allergy Clin Immunol Pract 2014;2:489-500.
17. Lee JX, Wojtczak HA, Wachter AM, Lee ML, Burns L, Chen D,
et al. Under- standing asthma medical nonadherence in an
adult and pediatric population. J Allergy Clin Immunol Pract
2015;3:436-7.
18. McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The
utility of fractional exhaled nitric oxide suppression in the
identification of nonadherence in difficult asthma. American
journal of respiratory and critical care medicine. Dec 1
2012;186(11):1102-1108.
19. Chan AH, Stewart AW, Harrison J, Camargo CA Jr, Black PN,
Mitchell EA. The effect of an electronic monitoring device
with audiovisual reminder function on adherence to inhaled
corticosteroids and school attendance in children with
asthma: a randomised controlled trial. Lancet Respir Med
2015;3:210-9.
20. Klok T, Kaptein AA, Duiverman EJ, Brand PL. Long-term
adherence to inhaled corticosteroids in children with
asthma: Observational study. Respiratory medicine. Sep
2015;109(9):1114- 1119.
21. Gamble J, Stevenson M, Heaney LG. A study of a multi-level
intervention to improve non- adherence in difficult to control
asthma. Respiratory medicine. Sep 2011;105(9):1308-
1315.
22. Fink JB, Rubin BK. Problems with inhaler use: a call for
improved clinician and patient education. Respir Care
2005;50:1360-74; discussion 74-5.
23. Melani AS, Bonavia M, Cilenti V, et al. Inhaler mishandling
remains common in real life and is associated with reduced
disease control. Respir Med 2011;105:930-8.
24. Kobayashi Y, Bossley C, Gupta A, et al. Passive smoking impairs
histone deacetylase-2 in children with severe asthma. Chest.
Feb 2014;145(2):305-312.
25. Rabinovitch N, Reisdorph N, Silveira , Gelfand EW. Urinary
LTE4 Levels Identify Children with Tobacco Smoke Exposure At
Risk for Asthma Exacerbation. J Allergy Clin Immunol. 2011
August ; 128(2): 323–327.
26. Mackay D, Haw S, Ayres JG, Fischbacher C, Pell JP. Smoke-
free legislation and hospitalizations for childhood
asthma. The New England journal of medicine. Sep
16 2010;363(12):1139-1145.
27. Stead LF, Koilpillai P, Lancaster T. Additional behavioural
support as an adjunct to pharmacotherapy for smoking
cessation. The Cochrane database of systematic
[ASMA SEVERA PROBLEMÁTICA EN PEDIATRÍA - Dr. Jorge Mackenney]